Eisai (OTC: ESALF)
Eisai Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Eisai Company Info
Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan.
News & Analysis
FDA Asks That Weight Loss Drug Belviq Be Pulled From the Market
A study finds an increased risk of cancer, and the manufacturer complies with the FDA's request.
Why Biogen Stock Is Crashing Today
Biogen's closely-watched Alzheimer's drug fails to move in the needle in two late-stage trials.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.